← Back to All US Stocks

ADTX Stock Analysis - Aditxt, Inc. AI Rating

ADTX Nasdaq Pharmaceutical Preparations DE CIK: 0001726711
Analysis Date: Mar 19, 2026 | Data as of: 2025-09-30
AI Rating
STRONG SELL
95% Confidence

Investment Thesis

Aditxt is in severe financial distress with negative stockholders' equity of -$7.7M, liabilities exceeding assets by $8.9M, and a critical liquidity crisis evidenced by a current ratio of 0.02x with only $163K in cash. The company is burning cash at an alarming rate (-$16.4M operating cash flow) while revenue has collapsed 79% YoY to just $2.8K, indicating complete business deterioration and imminent solvency risk.

ADTX Strengths

  • + Minimal capital expenditure requirements ($14.4K) reduces near-term cash drain
  • + Gross margin of 10.8% on remaining revenue shows some contribution on sales
  • + Single Form 4 filing suggests limited insider selling pressure in past 90 days

ADTX Risks

  • ! Negative stockholders' equity represents technical insolvency and shareholder capital destruction
  • ! Extreme liquidity crisis: current ratio of 0.02x indicates inability to meet short-term obligations
  • ! Revenue collapse of 79% YoY and only $2.8K in latest period suggests business has essentially ceased operations
  • ! Operating cash burn of -$16.4M with only $163K cash on hand creates immediate bankruptcy risk
  • ! $20.7M in total liabilities with negative equity creates unsustainable debt burden
  • ! Net loss of -$37.0M despite minimal revenue indicates severe operational distress

Key Metrics to Watch

ADTX Financial Metrics

Revenue
$2.8K
Net Income
$-37.0M
EPS (Diluted)
$-1,605.17
Free Cash Flow
$-16.5M
Total Assets
$11.8M
Cash Position
$163.0K

ADTX Profitability Ratios

Gross Margin 10.8%
Operating Margin -537,947.3%
Net Margin -1,336,192.1%
ROE N/A
ROA -313.7%
FCF Margin -594,118.9%

ADTX Balance Sheet & Liquidity

Current Ratio
0.02x
Quick Ratio
0.02x
Debt/Equity
N/A
Debt/Assets
175.1%
Interest Coverage
N/A
Long-term Debt
$3.1M

ADTX 5-Year Financial Trend

ADTX 5-year financial data: Year 2021: Revenue $105.0K, Net Income -$9.1M, EPS N/A. Year 2022: Revenue $933.7K, Net Income -$46.4M, EPS $-121.18. Year 2023: Revenue $933.7K, Net Income -$27.6M, EPS $-595.60. Year 2024: Revenue $645.2K, Net Income -$32.7M, EPS $-27,038.26.
Revenue
Net Income
EPS (right axis)

5-Year Trend Summary: Aditxt, Inc.'s revenue has grown significantly by 514% over the 5-year period, indicating strong business expansion. The most recent EPS of $-27,038.26 indicates the company is currently unprofitable.

ADTX Growth Metrics (YoY)

Revenue Growth
N/A
Year-over-year
Net Income Growth
N/A
Year-over-year
EPS Growth
N/A
Earnings per share
FCF Margin
-594,118.9%
Free cash flow / Revenue

ADTX Quarterly Performance

Quarterly financial performance data for Aditxt, Inc. including revenue, net income, and earnings per share.
Quarter Revenue Net Income EPS
Q3 2025 $748 -$12.8M $-548.78
Q2 2025 $1.0K -$7.3M $-3.45
Q1 2025 $1.0K -$5.7M $-8.12
Q3 2024 $6.9K -$9.9M $-111.07
Q2 2024 $44.3K -$5.7M $-4.19
Q1 2024 $79.7K -$6.0M $-9.21
Q3 2023 $124.5K -$5.7M $-47.95
Q2 2023 $214.7K -$5.7M $-0.93

Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.

ADTX Capital Allocation

Operating Cash Flow
-$16.4M
Cash generated from operations
Capital Expenditures
$14.4K
Investment in assets
Dividends
None
No dividend program

ADTX SEC Filings

Access official SEC EDGAR filings for Aditxt, Inc. (CIK: 0001726711)

Disclaimer: This analysis is generated by Claude AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: Mar 19, 2026 | Data as of: 2025-09-30 | Powered by Claude AI